Home aimed analytics

aimed analytics

aimed analytics

aimed analytics
Category
Business Description
Business concept in one sentence:
We accelerate, deepen, and democratize the knowledge gain from biomedical data for our customers from pharma and biotech.

Product and customer benefit:
We develop a platform that provides access to cutting-edge analysis of all kinds of biomedical data in an easy way.

It is obvious that the success of newly starting pharma and biotech companies is highly dependent on the usage of modern ways to analyze big biomedical data. However, due to high competition with other business areas for machine learning and data analysis specialists, talent is highly restricted. Companies lacking talent in this area miss on the promises of modern data analysis to cut down research costs and time-to-market resulting in a competitive disadvantage.

Our software-as-a-service platform allows the pharma and biotech companies to analyze biomedical data without access to trained personnel. In addition, the platform offers a high coverage of machine learning and technology specific analysis modules than can be combined to provide in-depth insights into efficacy, mechanism-of-action, toxicity and other parameters that are important to the success of drug candidates. Those crucial insights can be used to improve the drug development processes.

Our platform will democratize the usage of cutting-edge data analysis for pharma and biotech companies, which will greatly benefit the discovery of novel treatments of human diseases.
Long Business Description

Our USP:
The main unique selling point of aimed analytics is the platform and the architecture itself. The platform rethinks how biomedical data is analyzed. The modular system enables that medical data can be analyzed quickly and highly flexibly in order to answer a wide range of medical questions. This is crucial to cover the wide range of data analysis demands of our target customers. Furthermore, the underlying architecture allows the platform to grow with the progress and developments in the field of biomedical data analysis and hence to become more and more powerful.

The principle of the platform also enables that any input data can be used, as the system is easily adaptable to different data types (e.g. genomics data, imaging data or patient's medical records). Thus, aimed analytics brings a solution to the market that enables every owner of medical data to quickly gain deep biological/clinical/medical insights into their data. Our platform is designed in such a way that the customer can easily and intuitively request an analysis and eventually interact with the generated results in a highly interactive way. With the aimed analytics platform, we have created a universal solution for medical data analysis which is a critical building block for today's era of modern data-based medicine.
Our initial customers are small and medium pharma and biotech companies (2026, from 4.9 billion to 45.2 billion USD (global prognosis, Source: Statista)). Initially, we will focus on the niche of small and medium biotech and pharma companies. This creates a directly serviceable obtainable market of 450 million USD (Europe, North America and Japan).

No competitor currently offers an equivalent solution. Competitors either rely on pure services with limited scaling potential, on pure software solutions which do not provide the high flexibility of our system or they have focused on very specific medical issues.

One of our strategies for a market entry relies on our extensive network in international biomedical research institutes.
Achievements:
With the concept, that aimed analytics advanced into the above mentioned platform, Dr. Günther and Dr. Baßler were already able to convince experts and received the renowned EXIST-Gründerstipendium from the Federal Ministry of Economics and Climate Protection.

Furthermore, the idea has already been awarded and honored in numerous competitions, such as a University Bonn idea competition and the WOWFAKTOR ideas competition of the DIGITALHUB Bonn.

With regard to the status of the platform, the proof-of-concept was successfully completed. Currently, we have started the test phase of our alpha-version of the platform with pilot customers. Recruiting pilot customers has proven to be extremely easy, as there is already a high demand for our solution due to the strong need in the market. In the process, we have not yet launched any active marketing, but the demand solely generated through word-to-mouth. To take the platform to the next level of development, we are currently recruiting a developer to join our team.

Based in
Bonn
Tags
biomedicine, big data, analysis, saas
Total Funding
No funding announced yet
Founded
2023
Website
www.aimed-analytics.com

Articles about aimed analytics:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as aimed analytics? We're happy to assist you with our Startup Sourcing service.